Pharmafile Logo
Pharmafocus logo
Advanced Search

breast

Showing 10 posts of 10 posts found.

Hospitals in Oxfordshire to test for susceptibility to dangers of chemotherapy

July 1, 2019
Manufacturing and Production Cancer, Diagnostics, NHS, UK, breast, colon, oesophogus, pharma

Hospitals in Oxfordshire have introduced a genetic test which helps doctors predict the dangerous side effects of chemotherapy.   In …

News
Caner image

More cancer patients surviving for longer

October 31, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, bladder, breast, myeloma, oncology, ons, prostate

Cancer survival rates in England are continuing to improve, though many cancers still have an ‘extremely poor’ prognosis, according to …

News
Roche image

Roche’s Perjeta sees ‘impressive’ survival rates

September 29, 2014
Sales and Marketing Cancer, ESMO, Perjeta, Roche, breast, madrid

Roche’s oncology drug Perjeta combined with other medicines can help certain breast cancer patients live longer. This is according to …

News
Angelina Jolie image

‘Angelina effect’ sees BRCA tests soar in UK

September 19, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, angelina jolie, brac1, brad, breast, mastectomy

Referrals for testing for breast cancer risk more than doubled across the UK, after Oscar-winning American actress Angelina Jolie announced …

News
Cancer image

Cancer Research funding to be doubled

April 30, 2014
Research and Development, Sales and Marketing CRUK, Cancer, brain, breast, funding, lung

Cancer Research UK is to increase its research funding by 50% over the next decade as part of a new strategy …

News
roche image

Kadcyla launches in UK

February 13, 2014
Sales and Marketing CDF, Cancer, Kadcyla, NHS, Roche, breast

 Roche’s Kadcyla, indicated to treat an aggressive form of breast cancer, has launched today in the UK.Kadcyla (trastuzumab emtansine) which …

News

Pfizer breast cancer drug shows promise

February 4, 2014
Research and Development, Sales and Marketing Cancer, Pfizer, breast, femara, letrozole, palbociclib

Pfizer’s experimental breast cancer drug palbociclib has successfully extended progression-free survival in a Phase II trial.  The pill was administered …

News

PIP founder jailed for fraud

December 11, 2013
Medical Communications, Sales and Marketing breast, implants, pip, silicone

The boss of a French firm at the centre of a global health scare over faulty breast implants has been …

News

Afinitor recommended in Europe for breast cancer

June 22, 2012
Sales and Marketing Afinitor, CHMP, Cancer, Novartis, breast

A European committee is recommending Novartis’ Afinitor to treat women with a certain type of breast cancer. The CHMP says …

News
Herceptin image

New data shows Herceptin’s ability to increase survival

April 24, 2012
Research and Development, Sales and Marketing Cancer, Cochrane, Herceptin, Roche, breast

A new review of Roche’s breast cancer drug Herceptin has confirmed its ability to increase overall survival, but concerns remain …

News

Latest content

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024

FDA approves ImmunityBio’s Anktiva bladder cancer treatment

April 23, 2024

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024

Neurolentech and Kaerus Bioscience enter partnership for research on neurodevelopmental disorder

April 22, 2024

Ardena announces €20m expansion following first GMP approval

April 19, 2024